Literature DB >> 15635970

Seroprevalence and force of infection of varicella-zoster virus in Luxembourg.

J Mossong1, L Putz, F Schneider.   

Abstract

A serological prevalence survey was carried out in Luxembourg during 2000-2001 to determine the antibody status of the Luxembourg population against vaccine-preventable infections including varicella-zoster virus (VZV). ELISA tests performed on 2679 sera indicated that 96 (3.6%) of the study population were seronegative. Age-specific seroprevalence rose rapidly from approximately 70% at age 4 years to 90% at age 6 years to 95% at age 12 years. Significant heterogeneity of seroprevalence was observed between the six different primary schools. For age groups 0-5, 6-11 and 12+ years, we estimated an annual force of infection of 0.361 [95% confidence interval (CI) 0.31-0.415)], 0.204 (95% CI 0.12-0.29) and 0.05 (95% CI 0.024-0.082) respectively. Our results indicate that transmission of VZV is highest in children below the age of 6 years and that much lower levels of VZV transmission occur in secondary schools and throughout adulthood.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15635970      PMCID: PMC2870204          DOI: 10.1017/s0950268804002754

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  13 in total

1.  Seroepidemiological study of Pneumocystis jirovecii infection in healthy infants in Chile using recombinant fragments of the P. jirovecii major surface glycoprotein.

Authors:  Kpandja Djawe; Kieran R Daly; Sergio L Vargas; M Elena Santolaya; Carolina A Ponce; Rebeca Bustamante; Judith Koch; Linda Levin; Peter D Walzer
Journal:  Int J Infect Dis       Date:  2010-12       Impact factor: 3.623

2.  Seroepidemiology of hepatitis A and hepatitis B virus in Luxembourg.

Authors:  J Mossong; L Putz; S Patiny; F Schneider
Journal:  Epidemiol Infect       Date:  2006-01-25       Impact factor: 2.451

3.  Reconstructing historical changes in the force of infection of dengue fever in Singapore: implications for surveillance and control.

Authors:  Joseph R Egger; Eng Eong Ooi; David W Kelly; Mark E Woolhouse; Clive R Davies; Paul G Coleman
Journal:  Bull World Health Organ       Date:  2008-03       Impact factor: 9.408

4.  Comparison of the dynamics and correlates of transmission of Herpes Simplex Virus-1 (HSV-1) and Varicella-Zoster Virus (VZV) in a sample of the Israeli population.

Authors:  Batya B Davidovici; Ran D Balicer; Eyal Klement; Manfred S Green; Ella Mendelson; Zehava Smetana; Dani I Cohen
Journal:  Eur J Epidemiol       Date:  2007-08-01       Impact factor: 8.082

5.  Seroprevalence of varicella-zoster virus and predictors for seronegativity in the Amsterdam adult population.

Authors:  Gini G C van Rijckevorsel; Marjolein Damen; Gerard J Sonder; Maarten F Schim van der Loeff; Anneke van den Hoek
Journal:  BMC Infect Dis       Date:  2012-06-21       Impact factor: 3.090

6.  Seroprevalence of varicella zoster virus infection in child and adult population of Catalonia (Spain).

Authors:  Lluís Salleras; Angela Domínguez; Pere Plans; Josep Costa; Neus Cardeñosa; Núria Torner; Antoni Plasència
Journal:  Med Microbiol Immunol       Date:  2007-11-15       Impact factor: 4.148

7.  Varicella susceptibility and transmission dynamics in Slovenia.

Authors:  Maja Socan; Natasa Berginc; Jaro Lajovic
Journal:  BMC Public Health       Date:  2010-06-23       Impact factor: 3.295

Review 8.  A systematic review of varicella seroprevalence in European countries before universal childhood immunization: deriving incidence from seroprevalence data.

Authors:  K Bollaerts; M Riera-Montes; U Heininger; N Hens; A Souverain; T Verstraeten; S Hartwig
Journal:  Epidemiol Infect       Date:  2017-08-22       Impact factor: 2.451

9.  The epidemiology of Varicella Zoster Virus infection in Italy.

Authors:  Giovanni Gabutti; Maria C Rota; Marcello Guido; Antonella De Donno; Antonino Bella; Marta L Ciofi degli Atti; Pietro Crovari
Journal:  BMC Public Health       Date:  2008-10-27       Impact factor: 3.295

Review 10.  Varicella vaccination in Europe - taking the practical approach.

Authors:  Paolo Bonanni; Judith Breuer; Anne Gershon; Michael Gershon; Waleria Hryniewicz; Vana Papaevangelou; Bernard Rentier; Hans Rümke; Catherine Sadzot-Delvaux; Jacques Senterre; Catherine Weil-Olivier; Peter Wutzler
Journal:  BMC Med       Date:  2009-05-28       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.